Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;29(2):56-60.
doi: 10.1002/clc.4960290204.

Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation

Anna Nergärdh  1 , Rolf Nordlander, Mats Frick
Affiliations

Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation

Anna Nergärdh et al. Clin Cardiol. 2006 Feb.

Abstract

Background: A number of patients with persistent atrial fibrillation (AF) will not have sinus rhythm (SR) restored by direct current (DC) cardioversion.

Hypothesis: In patients with DC-refractory AF, oral pretreatment with sotalol increases the success rate at DC cardioversion.

Methods: Consecutive patients with persistent AF, refractory at a first DC cardioversion, were prospectively included. A comparative group of patients with AF not refractory at DC cardioversion was studied. Oral sotalol treatment was started after unsuccessful DC cardioversion and given at least 7 days before renewed cardioversion. Four weeks after cardioversion, an electrocardiogram was performed.

Results: In all, 53 patients were enrolled in the study. Forty-three (81%) in the sotalol group regained sinus rhythm (SR): 10 (19%) of these converted pharmacologically and 33 (62%) after a second DC cardioversion; SR was never restored in 10 patients (19%). After 4 weeks, SR was maintained in 29 patients (67%). The comparative group included 132 patients and differed significantly from the DC-refractory patients only with regard to weight. After 4 weeks, SR was maintained by 50 patients (37%) in this group.

Conclusions: In patients with persistent AF refractory to DC cardioversion, oral pretreatment with sotalol results in a high rate of SR restoration, either pharmacologically or by DC cardioversion. Maintenance of SR at 4 weeks is of sufficient clinical relevance to consider this treatment option in patients with AF refractory to DC cardioversion.

PubMed Disclaimer

References

    1. Kannel WB, Abbot RD, Savage DD, McNamara PM: Epidemiological features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018–1022 - PubMed
    1. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI: Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct‐current electrical cardioversion of chronic atrial fibrillation. Am J Cardiol 1991; 68: 41–46 - PubMed
    1. Page RL, Kerber RE, Russell JK, Trouton T, Waktare J, Gallik D, Olgin JE, Ricard P, Dalzell GW, Reddy R, Lazzara R, Lee K, Carlson M, Halperin B, Bardy GH: Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: The results of an international randomized, double‐blind multicenter trial. J Am Coll Cardiol 2002; 39: 1956–1963 - PubMed
    1. Taramasco V, Socas A, Ricard P, Levy S: Internal low‐energy cardioversion: A therapeutic option for restoring sinus rhythm in chronic atrial fibrillation after failure of external cardioversion. Europace 1999; I: 179–182 - PubMed
    1. Li H, Natale A, Tomassoni G, Beheiry S, Cooper P, Leonelli F, Easley A, Barrington W, Windle J: Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. Am J Cardiol 1999; 84: 1096–1098 - PubMed

Publication types

MeSH terms